| Bioactivity | CH401 peptide is a HER2-derived antigen peptide. After being bound to the artificial viral capsid by a self-assembled β-cyclic peptide, CH401 peptide is encapsulated in a lipid bilayer containing the lipid adjuvant α-GalCer, and can be studied as a self-adjuvant anti-breast cancer vaccine candidate[1]. |
| CAS | 503027-61-0 |
| Sequence | Tyr-Gln-Asp-Thr-Ile-Leu-Trp-Lys-Asp-Ile-Phe-His-Lys-Asn-Asn-Gln-Leu-Ala-Leu-Thr |
| Shortening | YQDTILWKDIFHKNNQLALT |
| Formula | C114H173N29O32 |
| Molar Mass | 2461.77 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ito K, et al. Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate. J Am Chem Soc. 2023 Jul 26;145(29):15838-15847. |
CH401 peptide
CAS: 503027-61-0 F: C114H173N29O32 W: 2461.77
CH401 peptide is a HER2-derived antigen peptide. After being bound to the artificial viral capsid by a self-assembled β
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.